Ursal, Jeraldin G.

HRN: 24-24-70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
CEFUROXIME 1.5GM (VIAL)
12/15/2023
12/22/2023
IV
1.5g
Q6hrs
Cellulitis 5th Digit
Rejected 
12/15/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/15/2023
12/22/2023
IV
600mg
Q8H
Infected Wound, L Hand
Waiting Final Action 
12/22/2023
CLINDAMYCIN 300MG (CAP)
12/22/2023
01/04/2024
PO
300
TID
Flexor Abscess Sheath
Waiting Final Action 
12/22/2023
CO-AMOXICLAV 625MG (TAB)
12/22/2023
01/04/2024
PO
625
BID
Flexor Abscess Sheath
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: